Viewing StudyNCT00000864



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000864
Status: COMPLETED
Last Update Posted: 2021-10-28
First Post: 1999-11-02

Brief Title: A Study to Test the Safety Tolerance and Metabolism of Abacavir 1592U89 ABC With Standard Zidovudine ZDV Therapy in Newborn Infants Born to HIV-1 Infected Women
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Organization Data

Organization: National Institute of Allergy and Infectious Diseases NIAID
Class: NIH
Study ID: ACTG 321
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Lead Sponsor Class: NIH
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Eunice Kennedy Shriver National Institute of Child Health and Human Development NICHD NIH